Molecular Profiling of Alveolar Soft Part Sarcoma 1 High resolution array CGH and gene expression profiling of alveolar soft part sarcoma

[1]  C. Leslie,et al.  Combining integrated genomics and functional genomics to dissect the biology of a cancer‐associated, aberrant transcription factor, the ASPSCR1–TFE3 fusion oncoprotein , 2013, The Journal of pathology.

[2]  P. Komminoth,et al.  Pathology and Genetics of Tumours of Soft Tissue and Bone , 2013 .

[3]  An-Qin Zhang,et al.  Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels. , 2012, International journal of oncology.

[4]  Wei Liu,et al.  Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[5]  P. Mukeňsnabl,et al.  Clinical significance of hypermethylation status in NSCLC: evaluation of a 30-gene panel in patients with advanced disease. , 2011, Anticancer research.

[6]  P. V. van Diest,et al.  Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer , 2011, The Journal of pathology.

[7]  Jürgen Hoffmann,et al.  Interleukin‐6 promotes tumorigenesis by altering DNA methylation in oral cancer cells , 2011, International journal of cancer.

[8]  F. Algaba,et al.  Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guérin response in patients with T1G3 high-risk bladder tumours. , 2011, European urology.

[9]  J. Rubenstein,et al.  Lhx6 and Lhx8 Coordinately Induce Neuronal Expression of Shh that Controls the Generation of Interneuron Progenitors , 2011, Neuron.

[10]  Ying Jin,et al.  Pax6 is a human neuroectoderm cell fate determinant. , 2010, Cell stem cell.

[11]  T. Izumi,et al.  Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma. , 2009, Cancer genetics and cytogenetics.

[12]  R. Shoemaker,et al.  BMC Cancer BioMed Central Research article Gene expression profiling of alveolar soft-part sarcoma (ASPS) , 2009 .

[13]  A. Lazar,et al.  Angiogenesis-Promoting Gene Patterns in Alveolar Soft Part Sarcoma , 2007, Clinical Cancer Research.

[14]  P. Schirmacher,et al.  Detection of the ASPSCR1–TFE3 gene fusion in paraffin‐embedded alveolar soft part sarcomas , 2007, Histopathology.

[15]  A. Folpe,et al.  Alveolar soft-part sarcoma: a review and update , 2006, Journal of Clinical Pathology.

[16]  L. Guillou,et al.  Alveolar soft-part sarcoma of the uterine corpus: Histological, immunocytochemical and ultrastructural study of a case , 2005, Virchows Archiv A.

[17]  M. Ladanyi,et al.  Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. , 2001, The American journal of pathology.

[18]  Alfons Meindl,et al.  The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 , 2001, Oncogene.

[19]  H. Miki,et al.  RT-PCR Suggests Human Skeletal Muscle Origin of Alveolar Soft-Part Sarcoma , 2000, Oncology.

[20]  R. Zarbo,et al.  Immunohistochemical profile of myogenin and MyoD1 does not support skeletal muscle lineage in alveolar soft part sarcoma. , 1999, Archives of pathology & laboratory medicine.

[21]  S. Knuutila,et al.  DNA copy number changes in alveolar soft part sarcoma: a comparative genomic hybridization study. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[22]  A. Gown,et al.  Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[23]  H. Correa,et al.  Trisomy 8 in alveolar soft part sarcoma. , 1995, Cancer genetics and cytogenetics.

[24]  V. Eusebi,et al.  Alveolar soft-part sarcoma: a new type of rhabdomyosarcoma? , 1994, Seminars in diagnostic pathology.

[25]  Mark L. Greenberg,et al.  Molecular genetic, cytogenetic, and immunohistochemical characterization of alveolar soft‐part sarcoma: Implications for cell of origin , 1992, Cancer.

[26]  P. Houghton,et al.  MyoD1 protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature. , 1991, The American journal of surgical pathology.

[27]  T. Hasegawa,et al.  Cytoskeletal properties of alveolar soft part sarcoma. , 1990, Human pathology.

[28]  H. Evans,et al.  Alveolar soft-part sarcoma : a study of 13 typical examples and one with a histologically atypical component , 1985 .